HZHaipeng Zhao

Haipeng Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haipeng Zhao has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Chen Wang

    National Center for Nanoscience and Technology

    2 shared publications
  • Qiaojun Fang

    Laboratory of Theoretical and Computational Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Key Laboratory of Standardization and Measurement for Nanotechnology, National Center for Nanoscience and Technology, Beijing, 100190, China; University of Chinese Academy of Sciences, Beijing, 100049, China; Sino-Danish Center for Education and Research, Beijing, 101408, China

    2 shared publications
  • Yanlian Yang

    National Center for Nanoscience and Technology

    2 shared publications
  • Bin Tu

    Laboratory of Theoretical and Computational Nanoscience, CAS Key Laboratory for Biological Effects of Nanomaterials & Nanosafety, CAS Key Laboratory of Standardization and Measurement for Nanotechnology

    1 shared publication
  • Lilusi Ma

    Key Laboratory for Biological Effects of Nanomaterials and Nanosafety (Chinese Academy of Sciences), Key Laboratory of Standardization and Measurement for Nanotechnology (Chinese Academy of Sciences), and CAS Center for Excellence in Nanoscience

    1 shared publication
  • Minxian Li

    Key Laboratory for Biological Effects of Nanomaterials and Nanosafety (Chinese Academy of Sciences), Key Laboratory of Standardization and Measurement for Nanotechnology (Chinese Academy of Sciences), and CAS Center for Excellence in Nanoscience

    1 shared publication

Latest Publications

  • Multivalent Peptide-Guided EZH2 Degradation Sensitizes Immune Checkpoint Therapy in TNBC

    by Minxian Li, Haipeng Zhao, Lilusi Ma, Qiaojun Fang, Yanlian Yang, Wenfeng Zeng, Xiaocui Fang, Chen Wang

    Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer. Although an immune checkpoint blockade can reduce metastasis, its effectiveness is hindered by the immunosuppressive microenvironment in TNBC. EZH2 is overexpressed in TNBC, and patients with high EZH2 expression are associated with poor prognoses. The study developed EIP103 as a first-in-class peptide degrader that targets EZH2 through multivalent, high-affinity interactions and induces conformational destabilization, representing a mechanism distinct from that of the small molecule inhibitor EPZ-6438. The results demonstrated that EIP103 induces immunogenic cell death through lipid peroxidation, resulting in enhanced immune cell infiltration. Additionally, molecular dynamics (MD) simulations and biochemical assays revealed that the peptide EIP103 binds to the SET domain of EZH2, altering its structure and triggering proteasomal degradation via Praja Ring Finger Ubiquitin Ligase 2 (PJA2)-mediated ubiquitination. Harboring both enzymatic inhibition and post-translational regulation properties, EIP103 exerts durable efficacy and activates antitumor immunity, making it a promising therapeutic candidate for TNBC.


  • Stable Peptide Binding Achieved through an Intrinsically Ordered Spiral Conformation with Ten-Glycine Spacing: Insights from MD Simulation

    by Obinna E. Onyemaobi, Haipeng Zhao, Bin Tu, Xiaocui Fang, Chen Wang, Yanlian Yang, Qiaojun Fang

    Previous experimental studies on position-coded multivalent peptide-peptide interactions demonstrated that introducing two tryptophan residues at varying positions within a 14-mer intrinsically disordered polyglycine (GW) peptide significantly affects its binding affinity and selectivity toward a partner homoglycine (G14) peptide. However, these studies lacked atomistic resolution and were unable to elucidate the structural mechanisms underlying the observed "volcano-like" binding trend. To address this limitation, we performed all-atom molecular dynamics (MD) simulations with enhanced sampling via replica exchange molecular dynamics (REMD) to investigate how tryptophan spacing influences binding behavior. Our results show that peptides with a 10-glycine separation between dual tryptophans (GW10) exhibit the strongest binding affinity to G14, consistent with the experimental data and validating the simulation approach. Notably, GW10 and related arginine and serine variants (GR10 and GS10) adopt stable, intrinsically ordered spiral conformations that form favorable binding pockets for G14. Energy decomposition, hydrogen bonding, and conformational analyses underscore the critical role of these ordered structures in modulating peptide-peptide interactions. These findings provide atomic-level insights into sequence-dependent binding and offer potential applications for peptide design, protein engineering, and the understanding of prelasso motifs relevant to protein folding.